A case-control study investigating genetic variations in NRF2 and KEAP1 in AD patients found that one haplotype allele of NRF2 is associated with an earlier onset of AD, suggesting that common variants of the NRF2 gene may influence disease progression [84]. This evidence concerns the gene KEAP1 and Alzheimer disease.